3 This area of research is in its very early stages and needs more work.
Centrally acting agents that affect sleep (including benzodiazepines) are generally not useful in this regard, and agents like the imidazopyridine zolpidem, which has been specifically designed to aid sleep, help some but not all people. We are just now starting to understand the importance of sleep patterns as they contribute to BP and cardiovascular risk. More good, focused research is needed to aid in the assessment and our understanding of these interactions.
